Clinical Features, Therapeutic Response, and Follow-Up in Pediatric Anti-N-Methyl-d-Aspartate Receptor Encephalitis: Experience from a Tertiary Care University Hospital in India

Abstract

Anti-NMDAR encephalitis requires prolonged immunomodulatory therapy. Intravenous pulsed methyl prednisolone therapy is beneficial in inducing and maintaining remission. It is safe, effective, and well tolerated by children with anti-NMDAR encephalitis. The duration of treatment required for sustained remission and cure needs to be determined in long-term studies.